Anders Viberg is a Medical Evidence Scientific Leader at AstraZeneca, a position held since 2024. Previously, they served as a Senior Analyst at The Dental and Pharmaceutical Benefits Agency, TLV from 2019 to 2024, and held various roles including Senior Consultant and Principal Consultant at qPharmetra between 2013 and 2018. Anders began their career at AstraZeneca R&D as a PK/PD specialist and later as a Pharmacometrician from 2006 to 2008. They earned an MSc in Pharmacy and a PhD in Pharmacometrics, both from Uppsala University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices